Healthcare distributor and services company McKesson (NYSE: MCK) will be reporting results this Wednesday after market close. Here’s what investors should know.
McKesson missed analysts’ revenue expectations by 4.1% last quarter, reporting revenues of $90.82 billion, up 18.9% year on year. It was a slower quarter for the company, with a decent beat of analysts’ EPS estimates.
Is McKesson a buy or sell going into earnings? Read our full analysis here, it’s free.
This quarter, analysts are expecting McKesson’s revenue to grow 21.7% year on year to $96.48 billion, improving from the 6.4% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $8.15 per share.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. McKesson has missed Wall Street’s revenue estimates four times over the last two years.
Looking at McKesson’s peers in the healthcare providers & services segment, some have already reported their Q2 results, giving us a hint as to what we can expect. CVS Health delivered year-on-year revenue growth of 8.4%, beating analysts’ expectations by 5.1%, and Guardant Health reported revenues up 30.9%, topping estimates by 10%. CVS Health’s stock price was unchanged after the resultswhile Guardant Health was down 9.3%.
Read our full analysis of CVS Health’s results here and Guardant Health’s results here.
Debates around the economy’s health and the impact of potential tariffs and corporate tax cuts have caused much uncertainty in 2025. While some of the healthcare providers & services stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 3.3% on average over the last month. McKesson is down 3.3% during the same time and is heading into earnings with an average analyst price target of $779.79 (compared to the current share price of $710.94).
Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
